Clinical outcomes of genomically guided trametinib monotherapy across cancer types: results from the IMPRESS-Norway trial

Background and purpose: Molecular profiling guides cancer treatment, by identifying actionable genomic alterations. The IMPRESS-Norway trial (NCT04817956) is a nation-wide precision medicine trial evaluating the efficacy of approved cancer drugs on a novel indication in patients with advanced cance...

全面介紹

書目詳細資料

Principais autores:	Kathinka Schmidt Slørdahl, Katarina Puco, Ragnhild Sørum Falk, Ingrid Dyvik, Sigmund Brabrand, Pitt Niehusmann, Eli Sihn Samdal Steinskog, Egil S. Blix, Åsmund Flobak, Irja Alida Oppedal, Sebastian Meltzer, Cecilie Fredvik Torkildsen, Hanne Blakstad, Kristina Lindemann, Sigbjørn Smeland, Anita Amundsen, Kjetil Taskén, Åslaug Helland
格式:	Artigo
語言:	Inglês
出版:	Medical Journals Sweden 2026-02-01
叢編:	Acta Oncologica
在線閱讀:	https://medicaljournalssweden.se/actaoncologica/article/view/45086
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!